MTOR and graft versus host disease: Immune reconstitution analyses focused on a detailed examination of the CD4+ T cell compartment in consideration of the patient's GVHD prophylaxis regimen, since earlier findings in murine models suggested a better expansion of Tregs with mTOR inhibitors compared with CsA [18].